A
Anthony Gamst
Researcher at University of California, San Diego
Publications - 225
Citations - 28967
Anthony Gamst is an academic researcher from University of California, San Diego. The author has contributed to research in topics: Population & Dementia. The author has an hindex of 69, co-authored 221 publications receiving 24610 citations. Previous affiliations of Anthony Gamst include University of California & University of California, Los Angeles.
Papers
More filters
Journal ArticleDOI
The Diagnosis of Mild Cognitive Impairment due to Alzheimer’s Disease: Recommendations from the National Institute on Aging-Alzheimer’s Association Workgroups on Diagnostic Guidelines for Alzheimer’s Disease
Marilyn S. Albert,Steven T. DeKosky,Dennis W. Dickson,Bruno Dubois,Howard Feldman,Nick C. Fox,Anthony Gamst,David M. Holtzman,William J. Jagust,Ronald C. Petersen,Peter J. Snyder,Maria C. Carrillo,Bill Thies,Creighton H. Phelps +13 more
TL;DR: Criteria for the symptomatic predementia phase of Alzheimer’s disease (AD), referred to in this article as mild cognitive impairment due to AD, has four levels of certainty, depending on the presence and nature of the biomarker findings.
Journal ArticleDOI
HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study.
Robert K. Heaton,David B. Clifford,Donald Franklin,Steven Paul Woods,Christopher Ake,Florin Vaida,Ronald J. Ellis,S. Letendre,Thomas D. Marcotte,Joseph H. Atkinson,Monica Rivera-Mindt,Ofilio Vigil,Michael J. Taylor,Ann C. Collier,Camillo Marra,Benjamin B. Gelman,Justin C. McArthur,Susan Morgello,David M. Simpson,McCutchan Ja,Ian Abramson,Anthony Gamst,Christine Fennema-Notestine,Terry L. Jernigan,Joseph K. Wong,Igor Grant +25 more
TL;DR: The most severe HAND diagnosis (HAD) was rare, but milder forms of impairment remained common, even among those receiving CART who had minimal comorbidities.
Journal ArticleDOI
Alzheimer's Disease Neuroimaging Initiative (ADNI): clinical characterization.
Ronald C. Petersen,Paul S. Aisen,Laurel A. Beckett,Michael C. Donohue,Anthony Gamst,Danielle J Harvey,Clifford R. Jack,William J. Jagust,Leslie M. Shaw,Arthur W. Toga,John Q. Trojanowski,Michael W. Weiner +11 more
TL;DR: The Alzheimer's Disease Neuroimaging Initiative has successfully recruited cohorts of cognitively normal subjects, subjects with mild cognitive impairment (MCI), and subjects with Alzheimer disease with anticipated baseline characteristics and the CSF measures heralded progression of clinical measures over 12 months.
Journal ArticleDOI
HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors
Robert K. Heaton,Donald Franklin,Ronald J. Ellis,J. Allen McCutchan,Scott Letendre,Shannon LeBlanc,Stephanie Corkran,Nichole A. Duarte,David B. Clifford,Steven Paul Woods,Ann C. Collier,Christina M. Marra,Susan Morgello,Monica Rivera Mindt,Michael J. Taylor,Thomas D. Marcotte,J. Hampton Atkinson,Tanya Wolfson,Benjamin B. Gelman,Justin C. McArthur,David M. Simpson,Ian Abramson,Anthony Gamst,Christine Fennema-Notestine,Terry L. Jernigan,Joseph K. Wong,Igor Grant +26 more
TL;DR: In this article, the authors used comparable methods of subject screening and assessments to classify neurocognitive impairment (NCI) in large groups of HIV + and HIV − participants from the pre-CART era (1988-1995, N = 857) and CART era(2000-2007; N = 937).
Journal ArticleDOI
Estrogen Replacement Therapy for Treatment of Mild to Moderate Alzheimer Disease: A Randomized Controlled Trial
Ruth A. Mulnard,Carl W. Cotman,Claudia H. Kawas,C H van Dyck,Mary Sano,Rachelle S. Doody,Elizabeth Koss,Eric Pfeiffer,Shelia Jin,Anthony Gamst,Michael Grundman,Ronald G. Thomas,Leon J. Thal +12 more
TL;DR: The study does not support the role of estrogen for the treatment of this disease, nor does it improve global, cognitive, or functional outcomes in women with mild to moderate AD.